R espect for autonomy implies that individuals should be allowed to make their own treatment decisions, typically in consultation with a clinician. Yet many people, including the majority of those at the end of life, are not able to make decisions. [1] [2] [3] Moreover, the majority of individuals do not complete an advance directive or otherwise leave clear instructions for how they want to be treated during periods of decisional incapacity. 4 Designated surrogates make decisions for incapacitated individuals who completed a durable power of attorney while competent. For incapacitated individuals who did not designate a surrogate while competent, the next of kin makes treatment decisions. Surrogates, whether patient designated or next of kin, are instructed to make decisions based on the substituted judgment standard, making the treatment decision they think the individual would have made if he or she were capable. 5, 6 Proponents argue that this approach extends individual autonomy by allowing individuals' preferences and values to guide how they are treated, even when they are not able to make their own decisions.
No systematic analyses have attempted to identify individuals' goals with respect to treatment decision-making during periods of incapacity. As a result, it is unclear to what extent current practice promotes individuals' goals. In the absence of an advance directive, how do individuals want treatment decisions to be made for them? Does current practice of relying on the next of kin, and instructing them to use the substituted judgment standard, promote individuals' goals? To assess these questions, a systematic review of the empirical literature was conducted to evaluate how individuals want treatment decisions to be made for them during periods of decisional incapacity.
METHODS

Data Sources and Searches
PubMed, Scopus, Embase, CINAHL, and PsycINFO were searched for studies published in English that provide quantitative or qualitative empirical data on how adults want treatment decisions to be made for them during periods of decisional incapacity. Studies were eligible if they were indexed before August 2, 2010. The search combined Medical Subject Headings in three inclusion categories: end-of-life care, attitudes, and family or surrogate. (See Appendix for the specific terms used.)
Study Selection
The systematic search identified 6,551 articles, and the authors identified seven additional articles. (See Figure 1 for the selection process.) Two authors independently reviewed the titles of the articles and categorized them as ineligible, of unclear eligibility, possibly eligible, or probably eligible. Categorization was performed while blinded to the articles' authors and affiliations. Articles were judged to be ineligible only if the reviewer was confident, based on the title, that the article would not satisfy the inclusion criteria of providing quantitative or qualitative empirical data by surveying adults regarding how they want treatment decisions to be made for them during periods of decisional incapacity. Titles that both authors agreed clearly failed to satisfy these criteria were eliminated, leaving 273 potentially eligible studies. The same two authors read the abstracts (or first pages of articles without abstracts) of the 273 articles and ranked them as ineligible, of unclear eligibility, or likely eligible. This process identified 54 articles as being of unclear eligibility or likely eligible. Both authors independently read the full text of these 54 articles and identified 33 articles that satisfied the inclusion criteria. Review of the references of the 33 eligible articles yielded four additional eligible articles. The references of these four articles were reviewed, yielding no additional eligible articles.
To determine whether the systematic search missed any eligible articles, the two authors evaluated the references of a related systematic review, which evaluated the effect of making treatment decisions on surrogates. 7 This review identified three additional eligible articles. Review of the references of these three articles yielded no additional eligible articles. Finally, five researchers in the field were contacted to determine whether they were aware of any eligible articles that had been missed, yielding no additional eligible articles. Thus, in total, 40 articles met the inclusion criteria.
Data Extraction and Quality Assessment
Two authors independently read the 40 eligible articles and extracted data on study location, number and type of respondents, response rate, methods, main findings, and limitations. When the extracted data from two different articles appeared to be related, the corresponding authors were contacted to determine whether the two articles were based on the same data set.
Two authors assessed the methodological strength of the eligible articles by giving them one point for each of 12 criteria that they satisfied. (See Table 1 for specific criteria.) When a criterion was not mentioned in the article, it was regarded as not satisfied. The final strength score is intended to reflect the extent to which the articles provide valid data relevant to the inclusion criteria used in the present review.
The quantitative articles used a range of different instruments, making it impossible to conduct formal statistical analyses on the aggregate results. The reviewed data are thus presented as a narrative summary. 8 
RESULTS
Identified Studies
The literature search identified 40 articles published in English before August 2, 2010 , that met the inclusion criteria. These articles provided data from 36 distinct data sets. The number of individuals evaluated in the articles ranged from 12 to 8,000, for a total of 22,828 individuals evaluated. Twenty articles reported the views of elderly individuals, typically aged 65 and older, 14, 15, 17, 18, [20] [21] [22] [23] [24] 26, 27, [29] [30] [31] 33, [36] [37] [38] 42, 44 nine reported the views of terminally or seriously ill patients. 14, 16, 19, 28, 34, 37, 42, 45, 46 Ten articles focused on the views of particular patient or ethnic groups. 9, 25, 29, 30, 32, 35, 40, 41, 47, 48 Only six articles surveyed a larger cross-section of a given population. [10] [11] [12] [13] 39, 43 The articles focused on whom individuals wanted to be their surrogate if they could no longer make decisions for themselves. Thirteen articles also evaluated why individuals preferred a particular surrogate; nine evaluated how much leeway individuals thought that their surrogate should have when making treatment decisions.
The first article was published in 1987; 22 articles were published in 2000 or later. Twenty-nine of the articles surveyed individuals in the United States; three surveyed individuals in Canada; two each in France and Japan; one each in Sweden, Australia, and Singapore; and one in Japan and the United States. Twenty-six articles reported quantitative data from 25 distinct data sets, and 14 reported qualitative data from 11 unique data sets (Tables 2 and 3 ). The quantitative articles used a range of instruments. Most of the qualitative articles used semistructured interviews. The qualitative articles reported data using direct quotations, as well as general descriptors of the results, such as a lot, some, and a little.
Who Individuals Want to Make Decisions for Them
The identified articles indicated that the vast majority of respondents wanted close family members to make treatment decisions for them during periods of decisional incapacity (Tables 2 and 3 ). In six articles, most respondents preferred their spouse to make decisions. 11, 13, 18, 36, 37, 44 Twelve articles reported that most respondents preferred that their adult children act as surrogates. 14, 15, [20] [21] [22] [23] [24] 26, 27, 31, 37, 42 In one of these articles, individuals preferred their adult children as decision-makers because they assumed that their spouses would predecease them. 42 A minority of Of those who had not appointed a proxy previously but did so during the study (N = 147).
respondents in the various articles preferred that a nonfamily member and nonphysician make treatment decisions. 11, 14, 15, [20] [21] [22] [23] [24] 26, 31, 35, 39 This preference sometimes reflected the fact that the respondent did not have any immediate family. [20] [21] [22] 26 In other cases, individuals did not want their family members to be involved in making decisions because of disagreements or conflicts they had with their family. 9, 46 Fifteen articles, reporting the findings of 12 data sets, found that the majority of respondents wanted their family members to make decisions together. 11, [18] [19] [20] [21] [22] 28, 30, 34, 38, 42, 43, 45, 47, 48 One respondent identified as his preferred decision-maker: "My wife, my son, and daughter. I am a firm believer that these are joint decisions." 20 Another stated that decisions should be made by "My three daughters together…. They'd make them together. They'd just stick together." 42 Most respondents wanted their family members to consult with their clinicians during the decision-making process.
Reasons for Surrogate Preference
Fourteen articles, reporting the findings of 11 data sets, evaluated why respondents preferred a particular surrogate. 12, [14] [15] [16] [20] [21] [22] 29, 33, 38, 42, 46, 47, 48 Eleven of these articles found that most individuals wanted a family member to be their surrogate because the respondent assumed that family members would know their treatment preferences. 12, 16, [20] [21] [22] 29, 33, 42, 4647, 48 For example, one respondent explained the preference for her daughter on the grounds that "My daughter would choose what I would do in the situation." 46 In some cases, respondents' confidence in their family's ability to determine their own treatment preferences was based on previous discussions between the patient and family member: "I have talked to my son and daughter. In all probability I'll predecease them, so I thought that was good enough." 22 Seventeen articles provided quantitative data regarding whether respondents had any discussion with someone else regarding end-of-life decision-making; none quantified the frequency, length, or depth of discussion. 14, 15, 17, 19, 20, [22] [23] [24] [25] [26] [30] [31] [32] 41, 42, 45, 46 Of these 17 articles, 11 found end-of-life discussion rates of lower than 50%. 14, 15, 17, 19, 26, 30, 32, 41, 42, 45, 46 An additional five articles found rates lower than 70%. 20, [22] [23] [24] [25] Only one reported discussion rates higher than 70%. 31 Ten articles found that respondents preferred family members as surrogates based on trust. 14, [20] [21] [22] 33, 38, 42, [46] [47] [48] Some respondents trusted their family members to implement their wishes. For example, one respondent stated: "You need someone you have confidence in to carry out your wishes." 47 Others trusted their family members to protect their interests: "My daughter would have my best interest at heart." 46 
How Much Leeway Do Individuals Want to Grant Their Surrogates
Nine articles evaluated how much leeway individuals thought their surrogates should have when making treatment decisions for them.
9,10,16,18,32,33,41,45,46 One of these articles explicitly defined "leeway" as "freedom to do what they think is best for you." 41 Another used the term "leeway" without defining it. 18 Two articles incorporated some explanation of leeway in the question. 9, 10 For example, one asked respondents: "How much leeway do you want to give your proxies in interpreting your wishes?" 9 The remaining five articles evaluated the concept without using the term "leeway." 16, 32, 33, 45, 46 For example, one article reported respondents' views regarding "to what extent their proxy should respect their treatment preferences." 32 These nine articles found that the preferred amount of leeway varied widely. One quantitative article reported that 58% of respondents wanted their surrogates to have none or a little leeway, whereas 42% wanted their surrogates to have a lot or complete leeway. 41 Another quantitative article found that 63% of respondents wanted their surrogates to follow their advance directives strictly or as much as possible, whereas 33% wanted their surrogates to use their advance directives as a reference only, and 3% did not care if their wishes were followed. 32 The qualitative articles, which found that some respondents "granted permission to proxies to freely interpret their written preferences," whereas others insisted that their surrogates "follow their instructions precisely," supported these findings. 9 The reasons why respondents wanted their surrogates to have leeway or not also varied. Many respondents who wanted their wishes followed simply wanted to have some treatments and avoid others. Others regarded the following of their wishes as a way to avoid burdening their family.
9,10,18 One respondent stated: "follow my directions to the T, because I do not want anyone to feel guilty that they made the wrong decision." 9 Other respondents felt that giving their surrogate leeway would allow the surrogate to make treatment decisions that better promoted the patient's interests.
9,10,18
Study Strength
The median strength score of the identified articles was 7 out of 12 (range 2-10); 33 of the 40 articles scored 8 points or less. Several of the deficiencies are of particular importance. For example, 15 articles did not report a response rate, and five had response rates below 50% (Tables 1-3 ).
Limitations
The present findings are subject to at least five important limitations. First, the strength of the identified articles was low, with a median strength score of 7 out of 12. Second, only 13 articles, reporting the findings of 10 data sets, asked respondents why they preferred a particular surrogate or a particular method for making treatment decisions. Third, the studies were conducted in a range of groups in different countries around the world. Thus, the present data are not robust enough to detect significant differences in views between groups and in different countries. Similarly, the wide range of survey instruments used precludes subgroup analyses of the data. Fourth, the nine articles that assessed leeway relied on different understandings of the concept. Some understood leeway as flexibility in interpreting the individual's stated preferences; others understood leeway as the flexibility to make decisions that were not consistent with the individual's stated preferences. Fifth, most respondents were older, very ill, or both. Although this group of individuals represents those for whom decisional incapacity is most likely, it may have failed to detect differences based on age or generational cohort.
DISCUSSION
Systematic review of the published data on more than 22,000 respondents from 36 unique data sets suggests that individuals have three primary goals with respect to how treatment decisions are made for them during periods of decisional incapacity. First, the vast majority of individuals want their close family members to make treatment decisions, typically in consultation with the individual's doctors. Second, individuals want to be treated consistently with their own preferences and values; most believe that relying on their family to make decisions will promote this goal. Third, many individuals want to minimize the burden on their families.
In the absence of an advance directive, current practice relies on the next of kin to make treatment decisions for incapacitated individuals. Yet prior systematic reviews have found that family members often do not know patients' treatment preferences, 49 and family members often experience substantial burden when acting as surrogates. 7 The present findings, when combined with those of these prior systematic reviews, suggest that current practice is promoting only one of individuals' three primary goals with respect to decision-making during periods of incapacity. Current practice realizes individuals' primary goal that close family members make treatment decisions for them. Yet the way families currently make decisions likely undermines individuals' two other primary goals: receiving treatments they want and avoiding burden on their families.
Implications for Future Research
Future research should assess whether modifications to current practice, or alternative approaches, might better promote individuals' goals. In particular, future research will be needed to assess whether it is possible to involve family members in the decision-making process in ways that reduce the burdens on them and also increase the chances that individuals are treated consistent with their own preferences and values. 50 One approach that has gained considerable support is shared decision-making, which involves family members and clinicians making decisions together. 51, 52 Clinicians may be able to help clarify the circumstances and options and take on some responsibility for the ultimate decision. Unfortunately, data suggest that clinicians may be less able than family members to predict their patients' treatment preferences. [53] [54] [55] Thus, greater involvement of clinicians in the decision-making process may help to promote individuals' goal of reducing the burden on their family 7 while undermining their goal of being treated consistently with their own preferences.
A second approach that has been proposed is to provide family members with predictions for what treatment course the individual would want based on the individuals' sociodemographic characteristics. 56, 57 Future research will be needed to evaluate whether this approach increases the chances that individuals are treated consistently with their preferences; whether it reduces the burden on their families; and what patients think about this approach.
In addition to evaluating ways to promote all three of individuals' primary goals, future research should consider how individuals prioritize these goals. Do individuals care more about having their family involved in the decisionmaking process, about reducing the burden on their families, or about receiving the treatments they want? Answering this question will be especially important if future research fails to identify approaches that successfully promote all three goals.
Implications for Clinical Practice
What implications do the present findings have for clinical practice? First, clinicians should be aware that individuals often assume that their family members know their treatment preferences. Given that this often is not the case, 49 clinicians should encourage individuals to discuss their preferences with their designated surrogates and document them using an advance directive. These steps may increase the chances that at least individuals who have specific treatment preferences are treated consistent with them. 3 In addition, the presence of an advance directive often reduces the burden on surrogate decision-makers. 7 Second, in addition to specific treatment preferences, clinicians should encourage individuals to use their advance directives to document any preferences they have regarding how treatment decisions are made for them. To what extent is the individual concerned primarily with the treatments they receive versus who makes decisions for them versus the effect on their families? This information will help surrogate decision-makers to better respect individuals' preferences.
Third, some commentators have argued that current practice inappropriately directs surrogates to make the decision they think the individual would have made if capable. 58 These commentators argue that surrogates should instead have leeway to take into account considerations other than the individual's treatment preferences, including the effect of the treatment options on the family. Although the present findings suggest that many individuals want their surrogates to have substantial leeway, many others do not. In addition, those who want their surrogates to have substantial leeway often assume that this approach is more likely to result in their receiving the treatments they want. In contrast, some respondents who are concerned about the effect on their families want their advance directives to be followed strictly because they assume that this approach will reduce the burdens on their family.
These findings suggest that it is not possible to develop un unequivocal recommendation regarding how much leeway surrogates should have. In addition, simply asking individuals to specify the amount of leeway they want their surrogates to have may lead to confusion regarding the individual's ultimate goals. To address this concern, individuals could be encouraged to document their most important goal with respect to making treatment decisions for them during periods of decisional incapacity. Individual also might document how much leeway they want their surrogates to have and the reasons for granting their surrogates leeway or not.
CONCLUSION
Review of the published literature suggests that individuals have three primary goals with respect to treatment decision-making during periods of decisional incapacity: involve their family, being treated consistently with their own preferences and values, and minimize the burden on their family. In the absence of an advance directive, current practice attempts to promote individuals' goals by relying on family members to make treatment decisions using the substituted judgment standard. Yet previous reviews show that family members often do not know the individual's treatment preferences 49 and often experience substantial burden when acting as surrogates. 7 Clinicians should be aware of these findings and encourage individuals to discuss and document their own goals, including any specific treatment preferences and their preferences regarding how they want decisions to be made for them. Future research should consider whether modifications to current practice or alternative approaches might better promote all three of individuals' primary goals with respect to decision-making during periods of incapacity.
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